Showing 1–2 of 2 results for author: Obradović, F
-
Identification of Long-Term Treatment Effects via Temporal Links, Observational, and Experimental Data
Authors:
Filip Obradović
Abstract:
Recent literature proposes combining short-term experimental and long-term observational data to provide credible alternatives to conventional observational studies for identification of long-term average treatment effects (LTEs). I show that experimental data have an auxiliary role in this context. They bring no identifying power without additional modeling assumptions. When modeling assumptions…
▽ More
Recent literature proposes combining short-term experimental and long-term observational data to provide credible alternatives to conventional observational studies for identification of long-term average treatment effects (LTEs). I show that experimental data have an auxiliary role in this context. They bring no identifying power without additional modeling assumptions. When modeling assumptions are imposed, experimental data serve to amplify their identifying power. If the assumptions fail, adding experimental data may only yield results that are farther from the truth. Motivated by this, I introduce two assumptions on treatment response that may be defensible based on economic theory or intuition. To utilize them, I develop a novel two-step identification approach that centers on bounding temporal link functions -- the relationship between short-term and mean long-term potential outcomes. The approach provides sharp bounds on LTEs for a general class of assumptions, and allows for imperfect experimental compliance -- extending existing results.
△ Less
Submitted 6 November, 2024;
originally announced November 2024.
-
Measuring Diagnostic Test Performance Using Imperfect Reference Tests: A Partial Identification Approach
Authors:
Filip Obradović
Abstract:
Diagnostic tests are almost never perfect. Studies quantifying their performance use knowledge of the true health status, measured with a reference diagnostic test. Researchers commonly assume that the reference test is perfect, which is often not the case in practice. When the assumption fails, conventional studies identify "apparent" performance or performance with respect to the reference, but…
▽ More
Diagnostic tests are almost never perfect. Studies quantifying their performance use knowledge of the true health status, measured with a reference diagnostic test. Researchers commonly assume that the reference test is perfect, which is often not the case in practice. When the assumption fails, conventional studies identify "apparent" performance or performance with respect to the reference, but not true performance. This paper provides the smallest possible bounds on the measures of true performance - sensitivity (true positive rate) and specificity (true negative rate), or equivalently false positive and negative rates, in standard settings. Implied bounds on policy-relevant parameters are derived: 1) Prevalence in screened populations; 2) Predictive values. Methods for inference based on moment inequalities are used to construct uniformly consistent confidence sets in level over a relevant family of data distributions. Emergency Use Authorization (EUA) and independent study data for the BinaxNOW COVID-19 antigen test demonstrate that the bounds can be very informative. Analysis reveals that the estimated false negative rates for symptomatic and asymptomatic patients are up to 3.17 and 4.59 times higher than the frequently cited "apparent" false negative rate. Further applicability of the results in the context of imperfect proxies such as survey responses and imputed protected classes is indicated.
△ Less
Submitted 19 August, 2024; v1 submitted 31 March, 2022;
originally announced April 2022.
